Yanlei Liu

Prof. Dr. Yanlei Liu


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in Acta Biomaterialia
Verified
Journal Article
Closed access
BLBin Liu
Bin Liu
WCWen Cao
Wen Cao
GQGuanglei Qiao
Guanglei Qiao
SYShanying Yao
Shanying Yao
SPShaojun Pan
Shaojun Pan
DCDaxiang Cui
Daxiang Cui

1 April 2019 in Acta Biomaterialia
Verified
Journal Article
Closed access
FXFangfang Xia
Fangfang Xia
JNJiaqi Niu
Jiaqi Niu
YHYuping Hong
Yuping Hong
CLChenlu Li
Chenlu Li
WCWen Cao
Wen Cao
DCDaxiang Cui
Daxiang Cui

20 December 2019 in Nanoscale
Verified
Journal Article
Closed access
PDF file
WCWen Cao
Wen Cao
BLBin Liu
Bin Liu
FXFangfang Xia
Fangfang Xia
MDMeng Duan
Meng Duan
YHYuping Hong
Yuping Hong
DCDaxiang Cui
Daxiang Cui
The critical issue in nanoscale medicine delivery systems is the targeted efficiency to guarantee the maximum accumulation of nanodrugs in tumors to exert better therapeutic action. In this study, we adopted an active and potent strategy based on mesenchymal stem cells (MSCs) certified with excellent tumor-tropism ability to load and ship MnO2@Ce6 nanoparticles into a tumor site. Notably, under the premise of the negligible cellular toxicity of MnO2@Ce6 on MSCs, its considerable uptake by MSCs enabled this nanoplatform (MnO2@Ce6-MSCs) to distribute increasingly inside the tumor. Briefly, a Ce6 photosensitizer was bound to MnO2 nanospheres by physical adsorption, improving its own stability in blood circulation. Furthermore, the delivered MnO2@Ce6 could modulate the tumor microenvironment (TME) by high sensitivity to excess hydrogen protons (H+) and H2O2. Thus, O2 generated by these reactions served as an abundant source for 1O2 conversion under a 633 nm laser exposure, which overcame the crucial bottleneck of the unfavorable hypoxia condition in TME for photodynamic therapy (PDT). In addition, MnO2 decomposed into Mn2+, which was represented by high T1 relaxivity in magnetic resonance imaging (MRI). The Mn2+ was finally removed rapidly from the body by liver metabolism and kidney filtration. These results endowed the original nanoplatform with striking potential for MSC-guided, Ce6-converted, MRI-monitored PDT for further innovation of a clinical cancer diagnosis-treatment agent.

1 November 2020 in Acta Biomaterialia
Verified
Journal Article
Closed access
BLBin Liu
Bin Liu
GQGuanglei Qiao
Guanglei Qiao
YHYu Han
Yu Han
ESE Shen
E Shen
GAGabriel Alfranca
Gabriel Alfranca
DCDaxiang Cui
Daxiang Cui

6 February 2021 in Nanoscale
Verified
Journal Article
Closed access
PDF file
SFShanshan Fan
Shanshan Fan
YZYu Zhang
Yu Zhang
HTHaisong Tan
Haisong Tan
CXCuili Xue
Cuili Xue
YHYu He
Yu He
DCDaxiang Cui
Daxiang Cui
Schematic illustration of the synthetic process of Fe 3 O 4 @MnO 2 –Ce6/CSL and mechanism of the cellular uptake process and pH-/H 2 O 2 -triggered MRI/FL imaging and CT/PDT combination treatment.

13 January 2022 in Acta Biomaterialia
Verified
Journal Article
Closed access
HTHaisong Tan
Haisong Tan
YLYanlei Liu
Yanlei Liu
NHNan Hou
Nan Hou
SCShengsheng Cui
Shengsheng Cui
BLBin Liu
Bin Liu
DCDaxiang Cui
Daxiang Cui